Cavis Technologies

Cavis Technologies is a Swedish cardiovascular medtech company developing invasive diagnostic devices for interventional cardiology. Its lead product, Wirecath, is a pressure guidewire/catheter system designed to assess the severity of coronary artery narrowings and myocardial disease while reducing hydrostatic pressure error that can affect conventional pressure-wire measurements. The company positions the device as offering improved diagnostic accuracy, manoeuvrability, and cost-effectiveness for catheterization laboratories. Cavis Technologies was founded in 2015 and is based in Uppsala, Sweden. Available public information indicates a small private company focused primarily on advancing and commercializing its Wirecath device in Europe.